SWITCH BIOTECH AG

SWITCH Biotech uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders.

#SimilarOrganizations #People #Website #More

SWITCH BIOTECH AG

Industry:
Biotechnology Medical

Founded:
2008-01-01

Address:
Conway, Arkansas, United States

Country:
United States

Website Url:
http://www.switch-biotech.com

Total Employee:
1+

Status:
Active

Contact:
501-658-8269

Email Addresses:
[email protected]

Technology used in webpage:
South African Server Location


Similar Organizations

abound-bio-logo

Abound Bio

Abound Bio specializes in generating antibody-based biological therapeutics to meet medical needs in the fields of cancer.

biorealize-logo

Biorealize

Biorealize is a design, research, and manufacturing company that builds tools that make it easy to access biodesign

Founder


horst-domdey_image

Horst Domdey

Official Site Inspections

http://www.switch-biotech.com

Unable to get host informations!!!

Loading ...

More informations about "Switch Biotech AG"

Revolutionizing RNAi Therapies | Switch Therapeutics

Switch Therapeutics is a biotech company dedicated to revolutionizing RNA interference (RNAi) therapies with conditionally activated siRNAs (CASi). ... At Switch, we value an environment …See details»

Switch Biotech AG - Crunchbase Company Profile & Funding

SWITCH Biotech uses its broad knowledge and expertise of the molecular biology of the skin to develop drugs for various skin disorders. New. Resources. Advanced Search. Start Free Trial . …See details»

Switch Bioworks

Through a proprietary mechanism, microbes then switch on nitrogen fertilizer production. Led by Tim Schnabel, the Switch Bioworks team is made up of almost exclusively scientists and …See details»

Switch Therapeutics - Crunchbase Company Profile & Funding

Switch Therapeutics is a biotech company that develops RNAi therapies based on technology. The company was founded in 2020 and is based in San Francisco, California, United States. …See details»

SWITCH Biotech Corp. :: Canada - OpenCorporates

Free and open company data on Canada company SWITCH Biotech Corp. (company number 10998842), 11609 115 Street, #1, Osoyoos, BC, V0H 1V5See details»

Switch Biotech LLC - Drug pipelines, Patents, Clinical trials - Synapse

Explore Switch Biotech LLC with its drug pipeline, therapeutic area, technology platform, , Drug:SWT-02.100, SWT-01100, SWT-01113, SWT-01114, SWT-05105. ... The statistics for …See details»

SwitchKine AG – Swiss Biotech

As a Swiss Biotech Association member, you profit from our engagement with national and international stakeholders, receive privileged information, share knowledge, improve your …See details»

Patents Assigned to Switch Biotech AG - Justia Patents Search

Feb 22, 2011 Assignee: Switch Biotech AG Inventors: Christoph Bogedain, Gerhard Maass, Markus Hörer Use of polypeptides or nucleic acids for the diagnosis or treatment of skin …See details»

Switch Therapeutics appoints David M. Holtzman, M.D. to its …

– Biotech expert and renowned Alzheimer’s disease researcher, David M. Holtzman, M.D., joins Switch’s Scientific Advisory Board to support advancement of company’s novel …See details»

Auffanggesellschaft nach Insolvenzanmeldung der SWITCH …

Neuried. Das auf die Heilung von Hautkrankheiten und Wundheilungsstörungen spezialisierte Biotech-Unternehmen SWITCH Biotech AG stellte am 3. September 2004 einen Antrag auf …See details»

News - Switch Therapeutics

Dee Datta, Ph.D., co-founder and CEO of Switch Therapeutics, will participate in a virtual fireside chat at the Evercore ISI 2024 Emerging Biotech Conference… Read More Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology OfficerSee details»

Switch - Bioo

Biological switches activated with the touch of a plant. Designing and installing systems for smart cities, events, companies. Domotics and automations with living plants. From small scale …See details»

Research programme: skin disorders therapeutics - SWITCH Biotech

04 Sep 2023 Discontinued - Preclinical for Psoriasis in Germany (Topical) (SWITCH Biotech website, September 2023) You need to be a logged in or subscribed to view this content …See details»

Switch Bioworks Bags $17M to Develop Sustainable Fertilizers

Sep 6, 2024 The company is pursuing collaborations within the agriculture and biotech industries to further develop and commercialize its platform. Funding and Next Steps. Including a pre …See details»

Switch Bioworks Raises $17M in Series Seed Financing

With the addition of a pre-Seed round raised in 2022 and grants from organizations such as the Bill and Melinda Gates Foundation, Switch Bioworks has now secured over $25 million in …See details»

Ontario Bioscience Innovation Organization - BioTalent Canada

The Ontario Bioscience Innovation Organization (OBIOâ„¢) is a private sector, membership-based organization that is Ontario’s leading advocate for the life science sector. OBIO is engaged in …See details»

BioCentury - Leo Pharma, Switch Biotech deal

Feb 17, 2003 Leo received exclusive worldwide rights to a psoriasis target that was validated using Switch's genomics technologies under a 2001 deal to identify drug targets for psoriasis …See details»

Biotechnology Innovation Organization - Wikipedia

The Biotechnology Innovation Organization (BIO) is the largest advocacy association in the world representing the biotechnology industry. [ 1 ] [ 2 ] [ 3 ] It was founded in 1993 as the Biotechnology Industry Organization from a merger of the Industrial Biotechnology Association (IBA) and the Association of Biotechnology Companies (ABC), [ 4 ] and changed its name to …See details»

The most innovative biotech companies of 2025 - Fast Company

4 days ago In December, IO Biotech entered a loan agreement of up to €57.5 million from the European Investment Bank, the long-term lending institution of the European Union, to fund …See details»

BioEscalator companies attract record funding as investors switch …

Aug 17, 2021 Theolytics, PepGen, and MediMab Bio, all female-led biotech companies, secured Series A funding totalling £51M during the pandemic. In the Rose Review of female …See details»

linkstock.net © 2022. All rights reserved